Seller record · Telehealth service

Regenics

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The page selling compounded PT-141 in 10 mg and 20 mg vials says “PT-141 is FDA-approved specifically for premenopausal women with hypoactive sexual desire disorder (HSDD).” The one approved bremelanotide is Vyleesi, an autoinjector; a compounded vial is not that product. Other pages carry the line that compounded medications are not FDA-approved, which does not withdraw the claim on the product page. 1 more criterion also fails; see the table below.

At a glance

RegenicsTelehealth service

6/8criteria passed

Price: Membership $39 first month, then $79, plus medication
Sells: compounded semaglutide, compounded tirzepatide, brand Wegovy, and 7 more
FDA letters: None on file

Visit Regenics See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service with a clinic in Tarzana, California, selling compounded semaglutide and tirzepatide, brand Wegovy and Zepbound, and sermorelin, NAD+, glutathione, PT-141 and GHK-Cu cream under a monthly membership. Further peptides are shown only to signed-in members and are not recorded here.

Operating entity Regenics, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Regenics' semaglutide product page; Regenics' website
S2	Prescription gating	PASS	Regenics' weight loss pre purchase page; Regenics' checkout
S3	Pharmacy identification	PASS	Regenics' contact us page
S4	Compounding disclosure	FAIL	Regenics' PT-141 product page; Regenics' peptides page; accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557
S5	Analytical documentation	FAIL	Regenics' glutathione product page
S6	Business address	PASS	Regenics' contact us page; Regenics' website
S7	Price disclosure	PASS	Regenics' v2 page; Regenics' membership landing page; Regenics' sermorelin product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed providers evaluate whether treatment is indicated, four nurse practitioners are named, and the footer states that treatment is available only after a licensed clinician determines it is appropriate.Source: Regenics' semaglutide product page; Regenics' website.

S2PASSThe weight loss path opens on medical questions about height, current weight and goal weight. The Join Regenics button takes a $39 membership payment before any medical question, and the checkout states that medication requires provider approval and is not charged if treatment is not approved.Source: Regenics' weight loss pre purchase page; Regenics' checkout.

S3PASSThe contact page names Strive Pharmacy at 1275 E Baseline Rd #104, Gilbert, AZ 85233, with a telephone number, as the partner pharmacy that dispenses its medications.Source: Regenics' contact us page.

S4FAILThe page selling compounded PT-141 in 10 mg and 20 mg vials says “PT-141 is FDA-approved specifically for premenopausal women with hypoactive sexual desire disorder (HSDD).” The one approved bremelanotide is Vyleesi, an autoinjector; a compounded vial is not that product. Other pages carry the line that compounded medications are not FDA-approved, which does not withdraw the claim on the product page.Source: Regenics' PT-141 product page; Regenics' peptides page; accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557.

S5FAILThe glutathione page says the product is tested for purity and quality, and no certificate of analysis or lot document is published.Source: Regenics' glutathione product page.

S6PASS18133 Ventura Blvd Suite C, Tarzana, CA 91356, printed in the footer and on the contact page, where the home page says protocols are also delivered in person at its Tarzana clinic.Source: Regenics' contact us page; Regenics' website.

S7PASSA membership at $39 for the first month for new customers, then $79 a month, plus medication: compounded semaglutide from $119 a month and compounded tirzepatide from $199 a month. Sermorelin, the NAD+ injection and PT-141 each at $159 for members against $399, $299 and $249 without, and glutathione at $79 for members against $139.Source: Regenics' v2 page; Regenics' membership landing page; Regenics' sermorelin product page.

S8PASSNo FDA warning letter names Regenics or Regenics, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand Wegovy, brand Zepbound, sermorelin, NAD+ injection, glutathione injection, PT-141, GHK-Cu cream, testosterone.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141 Who sells GHK-Cu

Unpaid link. Regenics does not pay the site, and nothing is earned when it is used. Funding.

Visit Regenics

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.